3.96
+0.09(+2.33%)
Currency In USD
| Previous Close | 3.87 |
| Open | 3.87 |
| Day High | 4 |
| Day Low | 3.76 |
| 52-Week High | 5.84 |
| 52-Week Low | 0.97 |
| Volume | 134,786 |
| Average Volume | 216,273 |
| Market Cap | 18.87M |
| PE | -0.34 |
| EPS | -11.66 |
| Moving Average 50 Days | 4.07 |
| Moving Average 200 Days | 2.24 |
| Change | 0.09 |
If you invested $1000 in Entero Therapeutics, Inc. (ENTO) since IPO date, it would be worth $0.02 as of January 17, 2026 at a share price of $3.96. Whereas If you bought $1000 worth of Entero Therapeutics, Inc. (ENTO) shares 5 years ago, it would be worth $0.1 as of January 17, 2026 at a share price of $3.96.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand
Newsfile
Oct 01, 2025 12:30 PM GMT
Transaction positions ENTO in the high-growth AI energy-infrastructure market, amid a surge of multi-billion-dollar hyperscaler spending on data centers, and rapid growth in behind-the-meter energy storage solutionsBoca Raton, Florida--(Newsfile Corp
Entero Therapeutics, Inc. Announces Reverse Stock Split
Newsfile
Aug 14, 2025 1:15 PM GMT
Boca Raton, Florida--(Newsfile Corp. - August 14, 2025) - Entero Therapeutics, Inc. (NASDAQ: ENTO) (the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (G
Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules
Newsfile
Aug 11, 2025 11:30 AM GMT
Boca Raton, Florida--(Newsfile Corp. - August 11, 2025) - Entero Therapeutics, Inc. (NASDAQ: ENTO) (the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (G
Data not available